NCT03549936View on ClinicalTrials.gov

Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence Syndrome

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 9, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Neonatal Abstinence Syndrome
Interventions
OTHER

Low lactose or regular formula

"If infant is not breast feeding and parents plan to formula feed, following written informed consent, infant is randomized to receive low lactose formula or regular formula which arrives from milk lab blinded and labeled as formula A or formula B."

Trial Locations (1)

44019

MetroHealth Medical Center, Cleveland

All Listed Sponsors
lead

MetroHealth Medical Center

OTHER

NCT03549936 - Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence Syndrome | Biotech Hunter | Biotech Hunter